Article

Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical Implications

2026-08-21

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5b7927c-b888-57ed-9f2b-1c99c36cc86d
DOI: 10.7759/cureus.114959

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical ImplicationsDOI 10.7759/cureus.114959Read

Immunogenicity of rDNA-derived pharmaceuticalsSemantic proximity Read

TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product.Semantic proximity Read

Erosion of Dosage Compensation Impacts Human iPSC Disease ModelingSemantic proximity Read

Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development TherapeuticsSemantic proximity Read

Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapiesSemantic proximity Read

The case for eteplirsen: Paving the way for precision medicine.Semantic proximity Read

Polyglutamine disorders: Pathogenesis and potential drug interventionsSemantic proximity Read

Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsSemantic proximity Read